Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,906 | 4,861 | 4,506 | 2,668 | 3,524 |
| Marketable Securities | 3,175 | 3,154 | 3,102 | 4,076 | 4,141 |
| TOTAL | $7,112 | $8,262 | $7,729 | $6,878 | $7,681 |
| Non-Current Assets | |||||
| Intangibles | 241 | 244 | 247 | 0 | 0 |
| Other Non-Current Assets | 59 | 61 | 62 | 64 | 65 |
| TOTAL | $300 | $305 | $310 | $64 | $65 |
| Total Assets | $7,412 | $8,567 | $8,038 | $6,941 | $7,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,584 | 973 | 1,251 | 802 | 704 |
| TOTAL | $1,656 | $1,045 | $1,323 | $874 | $776 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72 | 72 | 72 | 72 | 72 |
| TOTAL | $722 | $740 | $758 | $776 | $794 |
| Total Liabilities | $2,378 | $1,784 | $2,081 | $1,649 | $1,569 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,484 | 4,484 | 4,484 | 2,803 | 2,844 |
| Retained earnings | -15,265 | -13,534 | -12,605 | -11,674 | -10,872 |
| Other shareholders' equity | 3 | 14 | 364 | 440 | -477 |
| TOTAL | $5,034 | $6,782 | $5,958 | $5,292 | $6,177 |
| Total Liabilities And Equity | $7,412 | $8,567 | $8,038 | $6,941 | $7,746 |